Prazosin for Nightmares in PTSD

Introduction to Prazosin Use

The American Academy of Sleep Medicine identifies prazosin as the first-choice pharmacologic therapy for PTSD-related nightmares, despite recent evidence downgrading its recommendation strength 1, 2

The American Academy of Sleep Medicine acknowledges that prazosin remains the first choice for pharmacologic therapy for PTSD-related nightmares, even after downgrading their recommendation based on a large contradictory 2018 VA study 1, 2

Multiple randomized controlled trials demonstrated prazosin's efficacy in reducing nightmare frequency and intensity in both military veterans and civilians with PTSD, with a strength of evidence that is considered moderate to high 3
A 15-week RCT in active-duty soldiers showed prazosin significantly superior to placebo on all primary outcome measures, with 64% of prazosin patients markedly or moderately improved versus 27% on placebo (P < .001), indicating a high level of evidence for prazosin's effectiveness 2
An 8-week RCT in 100 civilian trauma victims showed nightmare frequency decreased from 2.42 to 0.85 in the prazosin group versus 2.48 to 2.30 in placebo, providing moderate evidence for prazosin's efficacy in civilians 2

A large 2018 VA study of 304 veterans with chronic PTSD showed no significant difference between prazosin and placebo at 10 or 26 weeks on any outcome measure, which may be due to the high percentage of patients receiving maintenance antidepressants, providing low to moderate evidence against prazosin's effectiveness in this population 1, 2

Patients taking selective serotonin reuptake inhibitors (SSRIs) show diminished response to prazosin for PTSD symptoms, with total CAPS scores decreasing by 30.1 ± 3.8 in patients not taking SSRIs versus only 9.6 ± 6.8 in those on SSRIs, indicating a significant interaction between SSRIs and prazosin, with a high level of evidence 1, 2

Begin with 1 mg at bedtime to minimize first-dose hypotension risk, and increase gradually by 1-2 mg every few days until clinical response is achieved, with monitoring of blood pressure after the initial dose and with each significant dose increase, based on moderate to high evidence 5, 3

Civilians with PTSD: Average effective dose is 3-4 mg/day, while military veterans typically require higher doses ranging from 9.5-15.6 mg/day, indicating a moderate level of evidence for dosing recommendations 5, 3

Symptom return upon discontinuation: Nightmares frequently return to baseline intensity when prazosin is stopped, indicating it treats symptoms without modifying the underlying condition, with moderate evidence 3, 4
Orthostatic hypotension: The most frequently reported adverse event requiring careful monitoring, with moderate to high evidence 5, 3

The American Academy of Sleep Medicine recommends Image Rehearsal Therapy (IRT) as first-line treatment, which involves rewriting nightmare content and rehearsing positive scenarios for 10-20 minutes daily, with moderate evidence for its effectiveness 5, 4